Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients
NCT04497389
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class
Conditions
SARS CoV-2
Interventions
BIOLOGICAL:
Human Amniotic Fluid
Sponsor
University of Utah